RFA-AG-24-030: Consortium for Economic Research on AD/ADRD Prevention, Treatment, and Care Coordinating Center (U54 Clinical Trial Optional). Applications due October 30, 2023.
RFA-AG-24-031: Consortium for Economic Research on AD/ADRD Prevention, Treatment, and Care (R01 Clinical Trial Optional). Applications due October 30, 2023.
PAR-23-256: Feasibility Trials of the NIH Music-based Interventions Toolkit for Brain Disorders of Aging (R34 Clinical Trial Required). New and Renewal/Resubmission Applications due October 20, 2023 and AIDS applications due November 14,2023.
RFA-AG-24-050: Health Equity and the Cost of Novel Treatments for Alzheimer’s Disease (AD) and AD-Related Dementias (ADRD) (R61/R33 Clinical Trial Not Allowed). Applications due October 31, 2023.
RFA-RM-23-012: Community Partnerships to Advance Science for Society (ComPASS): Health Equity Research Hubs (UC2 Clinical Trial Optional). Applications due October 31, 2023. Technical assistance webinar on September 6 at 2:00pm ET. Learn more and register on NOT-RM-23-023.
RFA-AG-24-029: Behavioral and Social Research on the Role of Immigration on Life Course Health and Aging, including AD/ADRD (R21 Clinical Trial Not Allowed). Applications due November 3, 2023.
NOT-AG-23-044: Notice of Intent to Publish a Funding Opportunity Announcement for High-Priority Behavioral and Social Research Networks (R24 Clinical Trial Optional). First estimated application due date: November 1, 2023.
NOT-AG-23-040: Notice of Upcoming NIH Early Prediction of Alzheimer's Disease and Alzheimer’s Disease Related Dementias (AD/ADRD) Open Innovation Challenge. First estimated application due date: January 31, 2024
RFA-AG-24-048: Primary Care-Based Screening Tool and Intervention Development for the Detection and Prevention of Abuse and Neglect in Older and Vulnerable Adults With, or at Risk for, Mild Cognitive Impairment and AD/ADRD (R61/R33 Clinical Trial Required). Applications due October 20, 2023.
top of page
bottom of page